Indinavir Sulphate

Indinavir Sulphate

Form: Capsules

Strength: 200 mg, 400 mg

Reference Brands: Crixivan®(EU & US)

Category: Anti Viral

Indinavir Sulphate Capsules, marketed under brands like Crixivan® and Indivan®, are protease inhibitors used in combination antiretroviral therapy (cART) for HIV-1 management. Available in 200 mg and 400 mg strengths, Indinavir works by inhibiting viral protease enzymes, reducing HIV replication. Though newer ARVs have largely replaced it in developed countries, Indinavir remains in use in resource-limited settings. On PharmaB2B platforms, buyers can bulk source WHO-GMP-certified generics for use in HIV programs, NGO supply chains, and public tenders. Reliable, cost-effective, and essential for legacy HIV treatment protocols, Indinavir supports access to affordable antiretroviral care worldwide.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Zanamivir

Strength: 5 mg/blister

Form: Inhalation powder

Reference Brands: Relenza(EU & US)

View Details Get Enquiry
Oseltamivir Phosphate Capsule

Strength: Capsule- 30 mg, 45 mg, 75 mg; Oral Suspension - 6 mg/mL (reconstituted)

Form: Capsules and Oral solution

Reference Brands: Tamiflu(EU & US)

View Details Get Enquiry
Amantadine

Strength: Tab -100 mg; Capsule- 100 mg; Oral solution - 50 mg/5 mL; Extended-release capsule (ER) - 129 mg, 193 mg

Form: Tablet; Capsule; Oral Solution and ER Capsule

Reference Brands: Symmetrel(EU & US); Osmolex ER(US), Gocovri(US)

View Details Get Enquiry
Glecaprevir + Pibrentasvir

Strength: Glecaprevir- 100 mg + Pibrentasvir - 40 mg

Form: Tablet

Reference Brands: Mavyret (US); Maviret (EU)

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.